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Fear memory extinction (FE) is an important therapeutic goal for Posttraumatic stress
disorder (PTSD). Cotinine facilitates FE in rodents, in part due to its inhibitory effect
on the amygdala by the glutamatergic projections from the medial prefrontal cortex
(mPFC). The cellular and behavioral effects of infusing cotinine into the mPFC on FE,
astroglia survival, and the expression of bone morphogenetic proteins (BMP) 2 and 8,
were assessed in C57BL/6 conditioned male mice. The role of the α4β2- and α7 nicotinic
acetylcholine receptors (nAChRs) on cotinine’s actions were also investigated. Cotinine
infused into the mPFC enhanced contextual FE and decreased BMP8 expression by
a mechanism dependent on the α7nAChRs. In addition, cotinine increased BMP2
expression and prevented the loss of GFAP + astrocytes in a form independent on the
α7nAChRs but dependent on the α4β2 nAChRs. This evidence suggests that cotinine
exerts its effect on FE by modulating nAChRs signaling in the brain.
Keywords: fear conditioning, bone morphogenetic proteins, prefrontal cortex, cholinergic receptors, MLA
INTRODUCTION
Posttraumatic stress disorder (PTSD) represents a consequential set of reactions to a traumatic
event(s) perceived as threatening life and resulting in the person experiencing feelings of intense
helplessness and horror. Management strategies for PTSD include therapies to facilitate fear
memory extinction (FE), which have shown to inhibit fear responses (Rutt et al., 2018), but there
is a paucity of evidence to support long-term pharmacological and psychotherapeutic treatment
Abbreviations: AMY, Amygdala; ANOVA, analysis of variance; BLA, basolateral amygdala; BMPs, the bone morphogenetic
proteins; CS, Conditioned Stimulus; DHβE, dihydro-beta-erythroidine; FE, fear memory extinction; GFAP, glial fibrillary
acidic protein; HPA, hypothalamus-pituitary-adrenal; IN, intranasal; ITC, intercalated cells; MLA, methylcaconitine; mPFC,
medial prefrontal cortex; MRI, magnetic resonance imaging; nAChRs, nicotinic acetylcholine receptors; OF, open field; PI3K,
phosphoinositide-3 kinase; PTSD, posttraumatic stress disorder; TBS, Tris-buffered saline; TBST, TBS with 0.1% Tween 20;
TGF, transforming growth factor.
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options (Wessa and Flor, 2007). Furthermore, even if FE is
achieved with treatment, between 60 and 72% of patients
with PTSD re-experience a return of their symptoms, or
suffer for many years of them raising questions around the
mechanisms underlying effective short- and long-term FE
(Steenkamp et al., 2015).
Several mechanistic studies suggest the medial prefrontal
cortex (mPFC) plays a role in the consolidation of FE learning
(Quirk et al., 2000). Previous studies revealed that cotinine, is a
positive allosteric modulator (PAM) type II of the α7 nicotinic
acetylcholine receptors (nAChRs), enhanced contextual FE, by
mechanisms involving the activation of the extracellular-signal
regulated kinases (ERKs) (Zeitlin et al., 2012) and calcineurin A
(CaA) (Alvarez-Ricartes et al., 2018b) in the hippocampus (HIP)
of mice (Mendoza et al., 2018). In addition, orally administered
cotinine, prevented the loss of synaptic density in the PFC and
HIP of chronically stressed male mice (Grizzell et al., 2014).
PAMs type II of the nAChRs bind to allosteric sites inducing
a positive effect on receptor activity, by stabilizing its active
conformation and preventing its desensitization. This concept
describes very well the effect of cotinine that is a weak agonist
of the α7nAChR to the orthostatic site, but positively modulates
the activity of the human α7 receptors, increasing the amplitude
of the currents induced by nicotine and acetylcholine in Xenopus
oocyte expressing the human receptor (Terry et al., 2015).
Altogether, we proposed that cotinine is a positive allosteric
modulator of the receptor, though, we cannot discard that
cotinine may affect other effectors that indirectly act over the
nAChRs to modulate its activity. At our knowledge the model
of Xenopus Oocytes used by Terry and others is one of the best
models to characterize the modulation of the nicotinic receptors
by new drugs to minimize the risk of being affecting other
human effectors that will not be present in the oocyte. However,
structure-based docking studies investigating the binding of
cotinine to the α7 nAChRs, combined to cell based binding and
activity studies to test the ′′docking hits′′ using mutagenesis,
it could be used to determine the predicted direct interaction
of cotinine and the nicotinic receptors subunits as well as the
nature of the allosteric modulation involved. We have found that
Cotinine alters the mRNA expression of BMP2 and BMP8 in
the brain of restrained mice (unpublished observation). Because
BMPs control the expression of stress factors, we hypothesized
that their expression could also be affected by cotinine during
fear extinction by mechanisms dependent on the nAChRs.
The neurobiological mechanisms underlying the psychological
and physical consequences of trauma affecting FE appear to
also involve changes in the HPA axis components affecting
astrogenesis (Perez-Urrutia et al., 2017). In this respect, the bone
morphogenetic proteins (BMPs), members of the transforming
growth factor (TGFβ) family, broadly expressed in the brain, play
an important function in the CNS regulating astrogenesis (Imura
et al., 2008) and neurogenesis during development (Shaked et al.,
2008; Morikawa et al., 2016) and adulthood (Colak et al., 2008),
and perhaps their function can be affected in the brain by PTSD.
The primary purpose of this study was to determine the
cellular and behavioral effects of infusing cotinine into the PFC
on FE and the expression of bone morphogenetic proteins (BMP)
2 and 8, in C57BL/6 male mice. A secondary purpose is to identify
the role of the α4β2- and α7nAChRs on cotinine’s behavioral,
cellular and molecular actions. This investigation revealed that
the infusion of cotinine into the mPFC enhanced contextual FE,
glial fibrillary acidic protein (GFAP) + astrocytes survival, and
the BMP2/8 expression in the brain of conditioned mice by a
mechanism dependent on the nAChRs.
MATERIALS AND METHODS
Drugs
Cotinine (5S-1-methyl-5-(3-pyridyl) pyrrolidine-2-ona) was
obtained from Sigma-Aldrich (Saint Louis, MO, United States).
α4β2nAChR inhibitor dihydro-beta-erythroidine (DHβE)
and the α7nAChR inhibitor, methyllycaconitine (MLA) were
obtained from Tocris bioscience (Bristol, United Kingdom).
Animals
Male C57BL/6 mice, 3–4 months of age and 30–35 g of weight,
were obtained from the University of Chile (Santiago, Chile) and
maintained on a 12 h/12h light-dark cycle with ad libitum access
to food and water. Mice were maintained grouped (2–4 mice by
a cage) in a controlled environment with average temperatures
between 23–25◦C and 50–70% humidity. The protocols were
designed to minimize animal suffering and reduce the number
of animals used. Animal studies were performed in compliance
with the ARRIVE guidelines (Kilkenny et al., 2010) and after the
approval of the Institutional animal care and use committees of
the University of San Sebastián, Chile according to the Guide
of Animal care and use of laboratory animals of the National
Institute of Health (NIH publication 80-23/96). The authors
declare that every effort was made to reduce the number of mice
used and their level of disconfort and suffering.
Experimental Design
This study investigated the effect of cotinine infused directly
into the mPFC on depressive-like behavior, fear consolidation
and extinction as well as the expression of BMPs in the PFC
and HIP of mice subjected or not to fear conditioning (FC) and
FE (Figure 1).
Drug Treatments
Three-month-old mice (n = 8–13/condition) were weighed
and randomly assigned to treatment groups. Mice received
continuous infusions with vehicle or drugs delivered chronically
using ALZET R© Osmotic Pumps, infusion pumps for continuous
dosing of freely moving mice, for 2 weeks, starting 1 week before
FC until euthanasia. Mice received treatments with phosphate
buffer saline (PBS, pH 7.4), Cotinine (5 mg/ml) dissolved in
PBS (Cot 5), DHβE (2.14 µg/ml in PBS, 100 µl, 13 µg/day),
MLA (0.24 mg/ml in PBS, 100 µl, 3 µg/day, 3.3 nmoles), Cot
5 plus DHβE (2.14 mg/ml in PBS, 100 µl, 13 µg/day), and
Cot 5 plus MLA (0.24 mg/ml in PBS, 100 µl, 3 µg/day). The
dose of cotinine was based on the dose of IN cotinine that
promoted FE in C57BL/6 mice (Alvarez-Ricartes et al., 2018a).
The dose of DHβE and MLA was chosen based on previous
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FIGURE 1 | Experimental design. (A) the drawing represents the intracerebral infusion of treatments by osmotic pumps by continues delivery into the frontal cortex
of mice. (B) Time line of treatments, behavioral tests and final experimental procedures in the study.
studies (Laurier et al., 1994; Yeomans and Baptista, 1997; Panagis
et al., 2000; Laviolette and van der Kooy, 2003). The doses of
DHβE (10–300 µg, equivalent to 28–840 nmol) (Yeomans and
Baptista, 1997) and MLA (2, 6, 18 µg totales) have been shown to
be effective inducing behavioral changes following intra-cranial
administration (Panagis et al., 2000). We choose the lower dose
range for our experiments, considering that a continue infusion
of drugs will require lower doses than one-time intracranial
administrations.
Infusion of Drugs Into the Prefrontal
Cortex
The infusion of drugs into the mPFC was performed using
osmotic pumps as previously described (Besson et al., 2007). First,
mice were subjected to behavioral analysis and then subjected
to a stereotaxic surgery under anesthesia, with a mix including
Ketamine, xylazine, and acepromazin (80, 8 and 1 mg/kg), to
implant a cannula in the medial prefrontal cortex (AP:+ 2.0 mm;
L 1.5 mm, V 3.5 mm, angle 30◦) attached to a Alzet R© osmotic
pump (Alzet, Cupertino, CA, United States) filled with 100 µl
of PBS alone (Vehicle) or a drug solution in PBS. The rate of
delivery of drugs of the device was 0.25 µl/h and was kept for
14 days until the end of experiments. One week after surgery mice
underwent FC and FE.
Behavioral Analysis
One week following pump implantation, mice were conditioned
and 24 h later tested in the fear retention test. On the next
day, mice were subjected to daily FE trials for 5 days. Following
FE trials, mice were tested for locomotor function using the
open field test.
Fear Conditioning
Fear conditioning was performed as reported (Zeitlin et al.,
2012). The conditioning chamber (33 cm × 20 cm × 22 cm)
is surrounded by a sound-attenuating box that generates a
background white noise (72 dB) and contains a camera at the
top of the chamber connected to a computer. The conditioning
chamber contains a speaker on one side and a 24 V light on
the other, with a 36-bar insulated shock grid floor. Each mouse
was placed in the chamber for 2 min before the onset of a tone
lasting 30 s (2,800 Hz and 85 dB). In the last 2 s of the tone, mice
received a foot shock of 1 mA, kept in the conditioning chamber
for 2 min, and then returned to their home cages. The chamber
was sanitized with 70% ethanol and dried after each trial. Freezing
behavior was defined as the absence of all movement (except
for movement secondary to breathing) and was assessed using
Freezing behavior was measured using the Any-maze R© software
(Stoelting, CO, United States).
Fear Retention and Extinction Tests
Fear retention and FE experiments were performed as previously
described using the same cohorts of mice. To assess FR,
mice underwent re-exposure to the conditioning chamber, in
the absence of the unconditioned stimuli (foot-shock and
auditory cues), for 3 min in daily extinction trials. The
extinction trials persisted until the decrease in freezing behavior
reached an asymptote.
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Open Field Test
Open field is a reliable test evaluating the locomotor activity
and exploratory behavior in mice (Walsh and Cummins, 1976).
A period of pre-test habituation was carried out in which the
mice were placed individually in the apparatus for 10 min
on two consecutive days. The OF test device consisting of a
square, open-top, arena (40 cm × 40 cm × 35 cm) that
was virtually divided into two areas: peripheral and central
zones. The mice were placed in the corner of the arena
and allowed to roam freely for 25 min. The time (min),
distance (m), and speed (m/sec) of the mice in the arena were
recorded. The behavior of mice was documented using a camera
located above the arena and analyzed with the software Any-
Maze (Stoelting).
Brain Tissue Preparation
For the protein studies, after euthanasia by cervical dislocation,
the brains were removed, and the left hemispheres were
dissected and quickly frozen for Western blot analyses. The right
hemisphere was placed in 4% paraformaldehyde in PBS pH 7.4 at
4◦C for 24 h, and then embedded in 2% agarose molds.
Brain regions of interest were located using the Paxinos
Atlas (Paxinos and Franklin, 2001), and serial sections of
20 µm (n ≥ 3/mouse) were collected using the Vibratome
Leica VT1000S and mounted on positively charged slides
(Biocare Medical, Concord, CA, United States) for the
immunohistochemistry (IHC) analysis.
Western Blot Analysis
The protein analysis was performed using Western blot according
to our previously published protocol (Alvarez-Ricartes et al.,
2018b). The brain tissues were homogenized by sonication
in lysis buffer with phosphatase and proteases inhibitors
(Cell signaling technology, Danver, MA, United States). The
homogenates were centrifuged, and aliquots of the supernatants
used for the determination of protein concentration using
the Biorad kit (Bio-Rad, Hercules, CA, United States). Brain
extracts in SDS-denaturant loading buffer with equal amounts
of protein were separated by electrophoresis in an SDS-PAGE
(4–20%) gel and transferred to nitrocellulose membranes. After
the transfer, membranes were blocked with TBS containing
0.1% of Tween 20 (TBST) and skim milk 10% (w/v) for
45 min and incubated with primary and secondary antibodies.
The primary antibodies used included the rabbit polyclonal
anti-BMP8 (United States Biological life sciences, Marblehead
MA, United States, # 221074), rabbit polyclonal anti-BMP2
(Invitrogen PH131215), anti-Calcineurin A (Cell signaling
technology) and mouse monoclonal anti-GFAP (Bio SB,
BSB5567, Santa Barbara, CA, United States). For protein loading
and transfer control, rabbit polyclonal antibody against β-actin
(# 662102, Biolegend, San Diego, CA, United States) and
rabbit monoclonal antibody against β-Tubulin (Cell signaling
technology) were used. After incubation with antibodies,
membranes were washed and analyzed for immunoreactive
(IR) bands using the ECL imaging system and the NIH
image J software (National Institute of Health, Bethesda,
MA, United States).
GFAP + Cells and BMP8
Immunohistochemical Analysis
The analysis of GFAP + cells and BMP8 IR was performed
as previously described. Sagittal sections of the mPFC
(AP: + 1.8 mm, ML: 0.0 mm, DV: −2.5 mm) and the HIP
(Approx. Bregma−4.08 mm, interaural 4.92 mm) were collected
in PBS and processed for GFAP and BMP8 IR.
Brain slices were immersed in xylene and decreasing the
graduation of ethanol baths for hydration. Slices were then
subjected to antigenic recovery in buffer citrate (pH = 6) in
a pressurized saucepan (Biocare Medical, Walnut Creek, CA,
United States) for 30 min, and incubated in a 3% hydrogen
peroxide solution for 5 min, washed with PBS, and blocked with a
horse serum solution (Vectastain Elite ABC, Vector Laboratories,
Burlingame, CA, United States) for 10 min at room temperature
(RT). After blocking, sections were washed in PBS and incubated
with an antibody against GFAP 1:100 (Sigma) or BMP8 1:200
(Cell signaling technology) for 1 h at RT. After washing with PBS,
sections were incubated with a biotinylated secondary antibody
for 10 min. Then, sections were washed with PBS and incubated
with the amplifier solution from the Vectastain Elite kit for
10 min at RT. The reaction was visualized using ImmunoDetector
DAB (SB Bio Inc., Santa Barbara, CA, United States).
For counterstaining, sections were stained with hematoxylin
for 30 s, dehydrated in baths containing ascending concentrations
of alcohol and xylene, and mounted with synthetic resin.
For the IR analysis, for each mouse, three digital images were
randomly selected at 40X magnification in the areas of interest
(hippocampus and frontal cortex) (n = 5 mice/condition). The
images were taken using a digital camera attached to a light
microscope (Micrometrics, MilesCo Scientific, Princeton, MN,
United States) connected to a camera operated by commercial
software (Micrometrics SE Premium). The determination of the
area of the immunolabeling was calculated delimiting the IR areas
using the ImageJ software (National Institute of Health).
For these analyses, GFAP+ astrocytes were selected randomly
from the frontal cortex and the CA1, CA2, and dentate gyrus
regions of the hippocampus and quantified. Using a digital
camera on an inverted microscope, black and white images of
GFAP + astrocytes were obtained and processed with Image
J software. Using a 20X objective, cells were chosen randomly
in the same area selected for immunostaining, and the binary
overlay of a cell was created by thresholding. For all images
a threshold value was established at the level at which the
binary overlay entirely enclosed the cell body and projections. All
pixels above the threshold value were considered as belonging
to the cell images. Finally, the binary silhouette of the whole
cell was reduced to its one-pixel outline for estimation of
the fractal dimensions with the FracLac 2.5 ImageJ plug-
in Karperien and Jelinek (2015).
Statistical Analysis
All values were expressed as a mean ± standard error of the
mean. The behavioral differences between treatment groups were
assessed by one-way or two-way analysis of variance (ANOVA)
with post hoc Tukey analysis. P < 0,05 was considered statistically
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significant. All statistical analyses were performed with the
software GraphPad Prism 8 (GraphPad Software Inc., San Diego,
CA, United States).
RESULTS
Cotinine Infused in the mPFC Enhanced
Fear Extinction in the Conditioned Mice
To determine whether the infusion of cotinine into the mPFC
could alter FE, cotinine was infused into this region 1 week prior
to FC and FE. In the extinction trials, all PBS-treated mice showed
a decrease in freezing behavior with the time that reached a steady
state decrease by day 5. A repeated measure ANOVA throughout
the 5 days of extinction revealed a significant difference induced
by treatments [F(3,23) = 7.231, P = 0.03] and days [F(4,
92) = 15.22, P < 0.0001) on the freezing behavior. Post hoc
Tukey’s multiple comparison test revealed that the infusion of
cotinine alone did not change the acquisition or recall of the fear
memory. In the retention test, cotinine-treated conditioned mice,
showed a similar freezing reaction than PBS-treated conditioned
mice (P = 0.47). In the extinction trials, mice treated with
cotinine plus DHβE showed a trend of reduced retention of fear
memory when compared to mice treated with cotinine alone
but the difference did not reach statistical significance respect to
conditioned mice treated with cotinine alone. Mice treated with
DHβE alone induced a significant decrease in FE when compared
to DHβE plus cotinine (Figure 2A, P < 0.05). Conversely, mice
treated with cotinine plus MLA showed a significant impairment
in fear extinction when compared with PBS-treated and cotinine-
treated fear conditioned mice (P < 0.05) (Figure 2B). The
enhancement of extinction in cotinine-treated mice was lost in
mice co-treated with Cotinine plus MLA. The reduction in FE
was even more pronounced in the mice treated with MLA alone
than mice treated with cotinine plus MLA (Figure 2B).
Effect of Intracortical Cotinine on
Locomotor Activity in the Open Field Test
of Conditioned Mice
To determine the changes in locomotor activity induced by
the infusion of drugs using stereotaxic techniques, mice were
tested using the OF test for 25 min. The results did not show
significant differences between treatment groups in distance
travelled [F(4,26) = 0.981, p > 0.05; Figure 3A] or speed
[F(4,26) = 0.9919, P > 0.05] (Figures2C,D).
Effect of Cotinine Infused in the Medial
Prefrontal Cortex on GFAP + Astrocytes
Survival in the Brain of Conditioned Mice
Results demonstrate significant differences in GFAP + IR
between treatment groups in the different regions of the HF, CA1
[F(4,60) = 48.68, P < 0.0001]; CA3 [F(4,60) = 33.62, P < 0.0001];
DG [F(4,61) = 43.23, P < 0.0001] (Figure 3A), and the PFC
[F(4,65) = 75.46, P < 0.0001] (Figure 3B). Tukey’s post hoc
analyses revealed a significant reduction of GFAP IR in the
conditioned mice when compared to non-stressed mice in the
CA1 (P < 0.0001), CA3 (P < 0.0001), and DG (P < 0.0001) of
the HF, and the PFC (P < 0.0001) (Figure 3B).
The infusion of cotinine in the mPFC of the conditioned mice
prevented the loss of astrocytes showing a significantly higher
GFAP IR in the CA3 (P < 0.05), DG (P < 0.005), and PFC
(P < 0.0001) than the one present in the PBS-treated conditioned
mice (Figure 3B). The simultaneous treatment of the conditioned
mice with cotinine plus MLA in the PFC did not prevent the
effect of cotinine in enhancing GFAP IR, however, the infusion
of DHβE prevented the increase of GFAP IR induced by cotinine
in the conditioned mice that showed GFAP IR not significantly
different from the PBS-treated conditioned mice (P < 0.05) and
significantly different from the inhibitor alone (P < 0.001).
Cotinine Downregulated BMP8
Expression in the Prefrontal Cortex of
the Conditioned Mice
The analysis of the protein expression of BMP8 in the PFC
revealed a significant change in the expression of BMP8
between treatment groups [One-way ANOVA, F(4,56) = 12,33,
P < 0.0001]. Post hoc analysis showed that after FE, the total
BMP8 IR was not different between control non-conditioned
mice and the conditioned mice after FE (ns, P = 0.651).
However, after FE the cotinine-treated mice showed significantly
lower levels of BMP8 IR than PBS-treated mice in the PFC
(75% decrease, ∗∗P < 0.005) (Figures 4A,B). Conditioned mice
treated with cotinine plus MLA showed BMP8 IR levels in the
mPFC were not significantly different from conditioned mice
infused with cotinine alone, or non-stressed mice (P > 0.05)
(Figures 4A,B). The antagonism of the α4β2 receptors with
DHβE in the mPFC did not prevent the downregulation of BMP8
induced by cotinine.
Effect of Cotinine on BMP2 Levels in the
Prefrontal Cortex of the Conditioned
Mice
The results demonstrate a significant difference in the expression
of the mature form of BMP2 (mBMP2) between treatment
groups [One-way ANOVA, F(2,15) = 12.69, P < 0.001). Post
hoc analysis showed that cotinine-treated conditioned mice
showed significantly higher levels of mBMP2 IR than the
vehicle-treated conditioned and non-conditioned mice in the
PFC (P < 0.001) (Figure 5A). The evaluation of the effect of
the antagonism of the nAChRs on cotinine’s actions revealed
that neither MLA or DHβE prevented the increase induced by
cotinine on BMP2 level in the mPFC (P > 0.05) (Figure 5A and
Supplementary Figures 1a–c).
Effect of Cotinine on Calcineurin a Level
in the Prefrontal Cortex of Conditioned
Mice
It has been shown that Calcineurin A (CaA) is involved in FE
and cotinine, alike other antidepressants, increases its expression
in the HIP (Alvarez-Ricartes et al., 2018b). The results showed
a significant difference in CaA expression between treatment
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FIGURE 2 | Effect of cotinine infused into the prefrontal cortex on fear conditioning and extinction. Male mice, treated as described in Materials and Methods
section, were subjected to fear conditioning (FC) (A) and fear extinction (B) for five consecutive days in absence of presence of cotinine (Cot) treatment alone or plus
MLA (α7 nAChR antagonist) or DHβE (α4β2 nAChRs antagonist). Locomotor activity was also tested measuring distance travelled (C), and speed (D) in the open
field test. Statistical significance was evaluated using one-way ANOVA with Tukey post-test. ns, not significant, ** highly significant P < 0.01.
groups [One-way ANOVA, F(4,32) = 10.44, P < 0.0001]. The
post hoc analysis demonstrated that after FE, the cotinine-
treated conditioned mice showed a higher level of CaA than the
conditioned mice treated with PBS in the PFC (77% increase
P < 0.05). The evaluation of the effect of the antagonism of
the nAChRs on cotinine’s actions revealed that MLA prevented
the increase induced by cotinine on CaA level in the mPFC
(P < 0.001) (Figure 5B and Supplementary Figures 2a–c).
DISCUSSION
The understanding of the molecular mechanisms involved in
cotinine’s action is fundamental to discover new therapeutic
targets to promote FE in affected individuals. In here, it
was discovered that cotinine infusion in the mPFC enhanced
contextual FE and prevented astrocyte loss by mechanisms
involving the α7 and α4β2 nAChRs, respectively. In addition, it
was found that cotinine increased BMP2 and decreased BMP8
expression in the mPFC as evaluated after FE. The evidence
also suggests that cotinine acting on the nAChRs is required
to enhance FE by modulating the activity of the mPFC and
its connectivity with other regions of the fear loop such as the
AMY and the HIP.
The inhibition of α4β2 nAChR with DHβE did not have the
same effect that cotinine plus DHβE, indicating that the changes
in behavior induced by the concommitant inhibition of the α4β2
receptors during cotinine treatments were not the result of the
effect of the inhibitor itself, but the result of the inhibition
of cotinine acting on this nicotinic receptor. We propose that
DHβE alone freeze the receptor in its desensitized state but
cotinine inhibits this effect by altering the receptor protein
conformation. Previous studies showed that nicotine ameliorated
fear conditioning that has been blocked by glutamate receptor
inhibitors such as MK801 and that infusion of DHβE into the HIP
negatively affected the positive effects of nicotine on contextual
FC (Andre et al., 2008).
It has been proposed that different processes in the mPFC
are involved in the acquisition and recall of fear learning.
Because several neurons containing nAChRs project from the
mPFC to the HIP and AMY (Pitkanen et al., 2000), the
nAChR’s antagonists may interrupt the connectivity between
the mPFC and these regions also involved in FE. The mPFC
projects to several cortical and subcortical structures, including
the AMY, insular cortex, lateral hypothalamus, periaqueductal
gray area and rostral ventrolateral medulla (Vertes, 2004, 2006;
Hoover and Vertes, 2007). Previous studies revealed that lesions
of the infralimbic cortex (IL) in the mPFC resulted in a
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FIGURE 3 | Cotinine prevented astrocyte loss in the prefrontal cortex and hippocampal formation of conditioned mice. After fear extinction (FE), mice (n = 5–8
mice/group) infused with cotinine (Cot) or Cot plus MLA but not with Cot + DHb E, showed higher GFAP immunoreactivity (IR) in the hippocampus regions [CA1,
CA3 and the dentate gyrus (DG)], and medial prefrontal cortex (mPFC) of mice by an α4β2 nAChR-dependent mechanism. In the dentate gyrus (DG) also a
significant effect of the inhibition of α7nAChR antagonistwas also observed. (A) The pictures despict the pictograms of representative immunohistochemical analysis
of brain regions analyzed using a mouse anti-GFAP antibody; (B), Plots representing the area of IR in the brain tissues showed in panel A. Statistical significance was
evaluated using one-way ANOVA with Tukey posttest. ns, not significant, *** highly significant P < 0.001.
Frontiers in Pharmacology | www.frontiersin.org 7 April 2020 | Volume 11 | Article 303
fphar-11-00303 April 1, 2020 Time: 16:23 # 8
Oliveros-Matus et al. Cotinine Enhances Extinction Using nAChRs
FIGURE 4 | Cotinine decreased BMP8 expression in the prefrontal cortex of conditioned mice. Cotinine (Cot) almost suppressed the expression of BMP8 in the
prefrontal cortex of mice as detected after fear fear extinction (FE). Cot or Cot plus DHβE-infused mice (n = 5–8/group) showed significantly lower levels of BMP8
than mice infused with PBS, or Cot plus MLA. (A) The plot represents BMP8 immunoreactivity (IR) levels after treatments (B). The pictures depict the BMP8 IR in the
medial prefrontal cortex (mPFC) as measured after treatments. Cotinine inhibited BMP8 expression in the mPFC of mice by a α7nAChRs-dependent mechanism.
Statistical significance was evaluated using one-way ANOVA with Tukey posttest. ns, not significant, ** highly significant P < 0.01. ES, exposed to stress (FC).
significant spontaneous recovery of conditioned fear responses
after extinction in rats (Quirk et al., 2000). Changes in IL synaptic
activity occurs during the acquisition (Muigg et al., 2008) and
expression of extinction (Orsini et al., 2011, 2013; Orsini and
Maren, 2012). Recent findings indicate that the IL target the
basolateral AMY, which in turn recruits the intercalated cells to
suppress fear (Strobel et al., 2015).
In addition to the mPFC, the HIP is important for the retrieval
of FE memory associated with context (Maren et al., 2013). The
modulation of the fear renewal with the expression of the context-
dependent fear memories after extinction, involves enhanced
activity of hippocampal neurons proyecting to the AMY and
mPFC (Knapska and Maren, 2009; Knapska et al., 2012). In
agreement with this evidence, it has been shown that cotinine
by acting mainly in the PFC can positively influence astrocyte
survival in the HIP.
Previous studies found that infusion of MLA or DHβE into
the mPFC enhanced contextual FC. The data suggest that most
likely α4β2 nAChRs mediate the enhancement of contextual fear
conditioning by nicotine (Raybuck et al., 2008; Raybuck and
Gould, 2009, 2010). In here, it was that retention of fear memory
was not affected by infusion of cotinine into the mPFC, however,
cotinine plus the selective inhibitor of the α7nAChR induced
higher retention of the fear memory. Conversely, the infusion of
cotinine plus DHβE inhibited the fear response to the context in
the retention test.
Cotinine could prevent the enhancing of FC induced by DHβE
by acting on the α4β2 nAChRs in the mPFC, and preventing the
conformational changes induced by DHβE resulting in closed
or resting states. Future studies using siRNA technology and
additional antagonists would be required to discard the unspecific
effects of these antagonists on other cell factors. Mistaken effects
are unlikely considering the pharmacological profile of these
nicotinic antagonists is well known and the doses used are in
the range of doses previously investigated in the same strain of
mice at the same ages. More inteerstingly a previous study has
shown that the positive modulation of the α7nAChR in astrocytes
inhibits the inflammatory response induced by LPS (Patel et al.,
2017). Similarly, we found the effects of cotinine on astrocyte
structure and numbers.
Astrocytes represent more than 60% of the cells in
the brain, and have many functions in the CNS. These
functions include modulating the blood-brain barrier, supporting
neuronal plasticity and survival, providing neurons with energy
molecules and trophic factors and removing glutamate from the
extracellular space (Ashton et al., 2012; Honsek et al., 2012;
Navarrete et al., 2012).
Astrocytes function is affected in PTSD with stress
significantly decreasing the survival of astrocytes (Imbe
et al., 2012; Perez-Urrutia et al., 2017). A substantial reduction in
the number of astrocytes in the HIP and PFC of fear conditioned
and restrained rodents have been found. However, IN cotinine
(Alvarez-Ricartes et al., 2018b) and oral cotinine (Perez-Urrutia
et al., 2017) prevented astrocyte loss induced by stress in the
HIP and PFC of mice. The protective effect of cotinine toward
astrocytes in these regions during stress was prevented by the
antagonism of the α4β2 nAChRs with DHβE, but not by MLA,
with the exception of the DG that also showed a minor effect
of cotinine induced by MLA. This evidence suggests that the
effect of cotinine on astrocyte survival is mainly mediated by
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FIGURE 5 | Cotinine increased BMP2 and calcineurin A expression in the prefrontal cortex of conditioned mice. Calcineurin A (CaA) immunoreactivity (IR) was higher
in the prefrontal cortex (PFC) of cotinine-treated conditioned mice than PBS- treated conditioned mice or control non-shocked mice after fear extinction
(n = 8–10/group). Cotinine-treated mice showed significantly higher levels of BMP2 than the vehicle-treated and non-shocked mice. BMP2 (A) and CaA (B) IRs are
represented as the percentage of control non-stressed mice values and normalized to total actin levels. (C) The diagram summarizes the hypothetical signaling
pathways involved in the positive effects of cotinine on PTSD pathology. ES, exposed to stress (FC); Veh, vehicle; ns, not significant; Statistical significance was
evaluated using one-way ANOVA with Tukey post-test. *, Significant P < 0.05. **, highly significant (P < 0.01). ***, highly significant P < 0.001.
the α4β2 nAChRs. The involvement of other receptors such as
the α7b2 receptors mediating the effects of cotinine cannot be
discarded. GABAergic interneurons in the CA1 subregion of
the hippocampus express functional α7β2 nAChRs, which show
pharmacological sensitivity to DHβE (Liu et al., 2012).
In addition, the facilitation of FE by cotinine was accompanied
by a decrease of BMP8 and the increase of mBMP2 expression
in the FC. Like other members of the TGFb superfamily, BMPs
are synthesized as pre-proproteins synthesized at the rough
endoplasmic reticulum (ER). In the secretory pathway, a BMP
proprotein is cleaved on the C-terminal side by convertases,
to release the C-terminal peptide. The C-terminal peptide
homodimerizes by disulfide bonding to form the mature secreted
BMP (Sopory et al., 2006). Active BMP dimers result in the
activation of the SMAD proteins. It has been shown that proBMP-
2 binds to BMP receptor IA with a similar affinity to its mature
form (Hauburger et al., 2009), however, it induces a more delayed
effect on gene expression when compared to the mature form of
the peptide (von Einem et al., 2011).
Basolateral amygdalas also activate non-Smad signaling
pathways, including the mitogen-activated kinases (MAPKs)
p38 kinase, Erks, and c-Jun kinase (cJNK) as well as the
phosphoinositide 3-kinase (PI3K)/Akt pathway (Mueller and
Nickel, 2012). Interestingly, cotinine enhanced FE and activated
ERK, Akt and CaA in the hippocampus of male mice (Grizzell
et al., 2014; Alvarez-Ricartes et al., 2018b).
More importantly, like its effect on FE, the cotinine-induced
decrease in Bmp8 was dependent on the activity of the
α7nAChRs, but not by the antagonism of the α4β2 nAChRs.
The actual evidence is the first time that a connection between
the effect of cotinine on astrocytes or behavior with the changes
in BMPs expression. Previous evidence showing that BMPIIR
deletion promoted neurogenesis and reduced anxiety behavior
in rodents, supports the view that BMPs are involved in the
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regulation of mood and cognitive abilities in mice during stress
(McBrayer et al., 2015).
The promoter region of the gene that codifies for BMP8
contains four GC response elements (GREs). In fact,
dexamethazone upregulates BMP8 expression suggesting a
role mediating GC actions. In the PFC of non-stressed mice,
the IR for BMP8 was detected surrounding membranes, but the
pattern of distribution looks different in the PFC of conditioned
mice. Previous evidence suggests that inhibition of BMP8
mediates the positive effects of exercise on synaptic plasticity and
learning (Gobeske et al., 2009).
BMP2 is one of the most potent osteo-inductive BMPs and
one that has been approved by the American Food and Drug
Administration for clinical use for spinal fusions and bone
healing in humans (Govender et al., 2002). However, undesirable
side effects limit its use (Benglis et al., 2008).
Basolateral amygdala signaling is active in adult neural stem
cells and it is crucial to adult neurogenesis in the subependymal
zone. Conditional deletion of Smad4 or infusion of Noggin,
an extracellular antagonist of BMP, in adult neural stem cells
suppressed neurogenesis and lead to increased differentiation in
oligodendrocyte (Colak et al., 2008). In addition, a nuclear variant
of Bmp2 (nBmp2) that is translated from an alternative start
codon and has a nuclear localization signal overlapping the site
of proteolytic cleavage (Felin et al., 2010).
It is intriguing that BMP8 immunoreactivity was detected
around the plasma membrane in the non-conditioned mice.
However, the pattern of distribution changed with stress. New
investigations are required to assess the effect of stress on BMP8
translocation to other cell compartments in the brain.
The decrease in BMP8 and the increase of BMP2 involved
the α7- and α4β2 nAChRs, respectively. These changes can
be involved in the enhancement of FE, and the preservation
of astrocytes function. It is known that BMP2 participates in
astrogenesis and may also play a role a role in preventing
astrocyte decrease induced by cotinine during stress conditions.
In addition, the α7 receptor, which is positively modulated
by cotinine, is present in the astrocytes and microglia, and
its activation reduces neuroinflammation in several neurologial
conditions (Shytle et al., 2004; Rehani et al., 2008; Foucault-
Fruchard and Antier, 2017; Hoover, 2017). Thus an effect
of cotinine on microglia is very likely. Consistent with this
idea, it has been shown that cotinine inhibits the activation of
monocytes. Pre-treatment of monocytes with cotinine changes
the inflammatory response to Gram negative bacteria inhibiting
the production of cytokines upregulated by NF-kappaB signaling
such as TNF-a, interleukin (IL)-1b, IL-6, IL-12/IL-23 p40,
while stimulating the expression of the anti-inflammatory IL-
10. This anti-inflammatory effect was attained by acting on
the monocytic α7 nAChR by a mechanism involving the
PI3K/GSK-3beta pathway; but not NF-kB. Cotinine can prevent
the activation of microglia acting on these receptors to reduce
neuroinflammation and the consequent synaptic deficit and
brain disconnection induced by stress. The modulation of the
stress response by BMP proteins under conditions of stress,
may also be controlled by mechanisms involving the nicotinic
receptors and their downstream signaling factors. Thus, the
investigation of the BMPs as new therapeutic targets for
PTSD is guarantee.
CONCLUSION
Based on this evidence, we conclude that cotinine favors astrocyte
survival, and reduce the effect of stress on fear memory by
acting on the α7-α4β2 nAChR. Also, it is possible to hypothesize
that BMP2 and BMP8 proteins are involved in fear retention
and extinction in subjects that suffered chronic or traumatic
unscapable stress. Cotinine-induced inhibition of BMP8 and
stimulation of BMP2 expression may facilitate extinction
(Figure 5C). On the other hand, the positive modulation of
the α7nAChR may protect astrocytes, reduce inflammatory
responses and support cognition and mood stability. Cotinine
may induce BMP2 expression by activating transcription factors
downstream of ERK such as Sp1 (Kawamata and Shimohama,
2011), and this increase may promote synaptic plasticity and
astrogenesis in the mPFC.
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